Profile data is unavailable for this security.
About the company
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
- Revenue in ILS (TTM)2.76m
- Net income in ILS-28.36m
- Incorporated1994
- Employees5.00
- LocationCan-Fite Biopharma Ltd26 Ben Gurion StreetRAMAT GAN 5257346IsraelISR
- Phone+972 39241114
- Fax+972 39249378
- Websitehttps://www.canfite.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Millennium Food-Tech LP | 464.00k | -25.91m | 15.11m | 2.00 | -- | 0.1344 | -- | 32.56 | -0.9204 | -0.9204 | 0.018 | 3.44 | 0.0038 | -- | 3.40 | 232,000.00 | -21.38 | -- | -21.52 | -- | -- | -- | -5,584.27 | -- | -- | -0.17 | 0.00 | -- | 224.48 | -- | -84.01 | -- | -- | -- |
| Kadimastem Ltd | 0.00 | -12.01m | 20.55m | 32.00 | -- | -- | -- | -- | -1.22 | -1.22 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -115.17 | -155.33 | -1,153.60 | -1,831.12 | -- | -- | -- | -- | -- | -9.44 | 3.22 | -- | -- | -- | 47.14 | -- | -50.73 | -- |
| Nextage Therapeutics Ltd | 876.00k | -4.07m | 24.11m | -- | -- | -- | -- | 27.53 | -0.1396 | -0.1396 | 0.03 | -0.0958 | 0.672 | -- | 6.82 | -- | -322.44 | -188.94 | -- | -423.76 | 25.68 | 33.33 | -479.79 | -2,486.19 | -- | -18.46 | -- | -- | -- | 17.99 | 27.21 | -- | -- | -- |
| Tikun Olam Cannbit Pharmaceuticals Ltd | 44.23m | -88.89m | 30.59m | 51.00 | -- | 0.7127 | -- | 0.6916 | -1.43 | -1.43 | 0.7018 | 0.5051 | 0.379 | 2.87 | 19.85 | 867,215.70 | -80.56 | -30.17 | -99.81 | -35.04 | -0.4273 | -- | -212.57 | -146.42 | 0.5033 | -30.02 | 0.3778 | -- | -10.28 | -- | -84.28 | -- | -8.71 | -- |
| Wilk Technologies Ltd | 0.00 | -10.93m | 37.66m | 4.00 | -- | 5.45 | -- | -- | -0.1807 | -0.1807 | 0.00 | 0.1006 | 0.00 | -- | -- | -- | -80.10 | -266.55 | -96.15 | -298.65 | -- | -- | -- | -97,340.88 | -- | -39.62 | 0.4049 | -- | -- | -- | 36.02 | -- | -- | -- |
| Grace Breeding Ltd | 463.00k | -8.50m | 44.94m | -- | -- | 28.34 | -- | 97.05 | -2.36 | -2.25 | 0.1296 | 0.3998 | 0.0848 | 2.73 | 0.9636 | -- | -164.09 | -- | -206.24 | -- | 80.56 | -- | -1,935.21 | -- | 1.45 | -94.74 | 0.5103 | -- | 121.53 | -- | 23.10 | -- | -- | -- |
| X T L Biopharmaceuticals Ltd | 1.69m | -83.65m | 45.58m | 33.00 | -- | 0.5451 | -- | 26.99 | -0.3798 | -0.3798 | 0.0077 | 0.1535 | 0.0192 | -- | 0.7012 | 51,169.93 | -94.96 | -53.17 | -111.98 | -59.10 | -- | -2.33 | -4,953.75 | -1,084.42 | -- | -- | 0.00 | -- | -85.80 | -- | -7.97 | -- | -53.12 | -- |
| Cannassure Therapeutics Ltd | 11.00m | -1.18m | 50.23m | -- | -- | -- | 180.69 | 4.57 | -1.43 | -2.16 | 13.28 | -3.66 | 0.5329 | 1.37 | 4.47 | -- | -5.74 | -45.39 | -18.34 | -92.41 | 29.17 | -- | -10.77 | -83.49 | 0.0474 | 0.9011 | -- | -- | -67.44 | -- | 78.37 | -- | -72.23 | -- |
| Can Fite Biopharma Ltd | 2.76m | -28.39m | 55.83m | 5.00 | -- | 2.18 | -- | 20.20 | -0.0226 | -0.0226 | 0.0022 | 0.0171 | 0.0771 | -- | -- | 552,702.80 | -79.22 | -102.29 | -103.51 | -131.07 | -- | -- | -1,027.46 | -1,105.36 | -- | -- | 0.00 | -- | -8.27 | -27.92 | 24.96 | -- | -42.92 | -- |
| Purple Biotech Ltd | 0.00 | -69.79m | 59.53m | 20.00 | -- | 0.5149 | -- | -- | -0.2753 | -0.2753 | 0.00 | 0.42 | 0.00 | -- | -- | 0.00 | -40.57 | -37.24 | -47.99 | -41.28 | -- | -- | -- | -9,415.70 | -- | -- | 0.0098 | -- | -- | -- | 8.25 | -- | -28.45 | -- |
| Matricelf Ltd | 0.00 | -13.83m | 70.04m | -- | -- | 2.60 | -- | -- | -0.8777 | -0.8777 | 0.00 | 1.67 | 0.00 | -- | -- | -- | -39.69 | -- | -42.80 | -- | -- | -- | -- | -- | -- | -- | 0.0527 | -- | -- | -- | -10.77 | -- | -- | -- |
| DNA Group TR Ltd | 306.00k | -1.18m | 96.19m | 14.00 | -- | 1.21 | -- | 314.35 | -0.0088 | -0.0088 | 0.0025 | 0.6429 | 0.0038 | -- | 1.37 | 21,857.14 | -1.45 | -23.54 | -1.46 | -26.27 | -- | -- | -384.64 | -7,406.24 | -- | -- | 0.00 | -- | -45.36 | -- | 95.00 | -- | -- | -- |
| GFC Green Fields Capital Ltd | 0.00 | 15.70m | 123.57m | 2.00 | 7.90 | 0.7807 | 7.87 | -- | 1.56 | 1.56 | 0.00 | 15.77 | 0.00 | -- | -- | -- | 3.26 | 1.99 | 10.38 | 3.58 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 844.90 | 45.32 | -- | -- |
Data as of Jun 13 2024. Currency figures normalised to Can-Fite Biopharma Ltd's reporting currency: Israeli Shekel ILS
